Antonio Curti

9PUBLICATIONS
81CO-AUTHORS
Immunogenetics (incl. genetic immunology)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)BiomechanicsMedical biochemistry - amino acids and metabolitesHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 30, 2026
Dynamics of IDH1/2 mutated clones in acute myeloid leukemia challenge their use as universal MRD markers.

|Mar 06, 2025
Safety run-in and part 1 of GIMEMA AML1718: venetoclax combined with FLAI as induction treatment in non-low-risk AML.

Giovanni Marconi, Alfonso Piciocchi, Ernesta Audisio

|Feb 06, 2025
Fitness assessment in acute myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet.

Adriano Venditti, Raffaele Palmieri, Luca Maurillo

|Dec 31, 2024
Parallel single-cell metabolic analysis and extracellular vesicle profiling reveal vulnerabilities with prognostic significance in acute myeloid leukemia.

Dorian Forte, Roberto Maria Pellegrino, Paolo Falvo

|Dec 19, 2024
Olutasidenib demonstrates significant clinical activity in mutated IDH1 acute myeloid leukaemia arising from a prior myeloproliferative neoplasm.

Stéphane De Botton, Christian Récher, Jorge Cortes

|Jul 05, 2024
Risk-adapted MRD-directed therapy for young adults with acute myeloid leukemia: 6-year update of the GIMEMA AML1310 trial.

Adriano Venditti, Alfonso Piciocchi, Anna Candoni

Pageof 2

Frequent Collaborators

3 joint publications

Adriano Venditti

2 joint publications

Stéphane de Botton

2 joint publications

Luca Maurillo

2 joint publications

Christian Récher